SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-034593
Filing Date
2021-02-09
Accepted
2021-02-09 17:11:59
Documents
16
Period of Report
2021-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129011d8k.htm   iXBRL 8-K 30269
2 EX-4.1 d129011dex41.htm EX-4.1 84487
3 EX-5.1 d129011dex51.htm EX-5.1 16005
4 EX-10.1 d129011dex101.htm EX-10.1 157594
8 GRAPHIC g129011g32b36.jpg GRAPHIC 5108
  Complete submission text file 0001193125-21-034593.txt   494330

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20210208.xsd EX-101.SCH 3078
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20210208_lab.xml EX-101.LAB 18122
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20210208_pre.xml EX-101.PRE 11410
9 EXTRACTED XBRL INSTANCE DOCUMENT d129011d8k_htm.xml XML 3374
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 21607568
SIC: 8090 Services-Misc Health & Allied Services, NEC